FIELD: medicine.
SUBSTANCE: penetrating keratoplasty is performed, preoperative preparation is made and post-surgical treatment is performed using medicine blocking angiogenesis - bevacizumab by the suggested procedure.
EFFECT: method provides regress of the existing newly performed vessels, prevents cornea neovascularisation development in the early postoperative period after penetrating keratoplasty.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING NEOVASCULAR GLAUCOMA | 2009 |
|
RU2392912C1 |
METHOD OF TREATING CORNEAL NEOVASCULARISATION | 2013 |
|
RU2522387C1 |
METHOD FOR TREATING COMPLICATED PURULENT CORNEAL ULCER | 2006 |
|
RU2309710C1 |
METHOD OF CATARACT EXTRACTION AND INTRAOCULAR LENS IMPLANTATION DURING SIMULTANEOUS PENETRATING KERATOPLASTY WITH PARTIAL FIXATION OF TREPANNED CORNEA (VERSIONS) | 2023 |
|
RU2801490C1 |
METHOD FOR THE TREATMENT OF NEOVASCULAR GLAUCOMA | 2022 |
|
RU2789438C1 |
METHOD OF KERATOCONUS TREATMENT | 1997 |
|
RU2134562C1 |
METHOD FOR CORRECTING EYE SIGHT AFTER PENETRATING KERATOTRANSPLANTATION OPERATION | 2000 |
|
RU2159599C1 |
METHOD OF COMBINED TREATMENT OF SEVERE FORMS OF SECONDARY NEOVASCULAR GLAUCOMA | 2019 |
|
RU2708059C1 |
METHOD FOR EARLY DIAGNOSIS OF CORNEAL GRAFT REJECTION AFTER PENETRATING KERATOPLASTY | 2021 |
|
RU2770780C1 |
COMBINED PERILIMBAL CORNEA BIOSTIMULATION AND PHOTOTHERAPEUTIC KERATOSTROMECTOMY METHOD FOR TREATING THE CASES OF EPITHELIOENDOTHELIAL CORNEA DYSTROPHY | 2004 |
|
RU2277396C2 |
Authors
Dates
2009-10-10—Published
2008-06-17—Filed